Storify by Andrew Steen

The Biotech Startup Class of 2012: How many received SBIR/STTR awards?

My initial question...
Andrew Steen @steen1969
Of @ldtimmerman's Biotech Startup Class of 2012 xconomy.com/national/2012/…, how many received SBIR/STTR awards? Anyone know? @lisa_kurek?
Mon, Jan 21 2013 10:06:38
Reply Retweet Favorite
...spurred on by Luke.
Luke Timmerman @ldtimmerman
@steen1969 @lisa_kurek Don't know. But how far can a company go on SBIR/STTR awards? Far enough to entice a pharma partner?
Mon, Jan 21 2013 10:10:28
Reply Retweet Favorite
Some answers came back.
Kevin Chow @kevintoshio
@ldtimmerman @steen1969 @lisa_kurek Altor Bioscience has done well with SBIRs, though not solely. Genentech collaboration too.
Mon, Jan 21 2013 10:52:27
Reply Retweet Favorite
Laura Strong @scientre
.@ldtimmerman @steen1969 Tough to get there on SBIR alone. Even if SBIR/STTR cover major sci activities, need IP, gaps bw grants, etc
Mon, Jan 21 2013 10:54:53
Reply Retweet Favorite
Michael Koeris @mkoeris
@scientre @ldtimmerman @steen1969 agree - SBIR (less so STTR) don't provide acceleration at all. They are at best sustaining IMHO
Mon, Jan 21 2013 11:01:09
Reply Retweet Favorite
Roger Frechette @rofrechette
@scientre @ldtimmerman @steen1969 Having built and sold a grant only start-up, its highly unlikely that SBIR/STTR alone can build value.
Mon, Jan 21 2013 11:56:46
Reply Retweet Favorite
And an answer to the original question via SBIR Source. SBIR Source is a good tool, if you haven't tried it.
SBIR Source @sbirsttr
@steen1969 5 won awards, ~20% of the US firms on the list. ImaginAb, Thesan, Vascular, Novira, Cerecor. ow.ly/h0kMo
Mon, Jan 21 2013 13:39:55
Reply Retweet Favorite
Indeed, five companies on the list have won awards. They each have raised significant amounts of additional capital.
Share
Share on Facebook
Share on Twitter
Share on Pinterest
Share on Google+
Share on Linkedin
Share by email
louisvillelifescience.files.wordpress.com
·
Tue, Jan 22 2013 10:10:43
Two of the companies are based in California. None are based in Massachusetts. I note that because the below heat map of NIH SBIR/STTR awards by State shows Massachusetts to be the "hottest" spot.
Share
Share on Facebook
Share on Twitter
Share on Pinterest
Share on Google+
Share on Linkedin
Share by email
nexus.od.nih.gov
·
Tue, Jan 22 2013 08:45:28
I wasn't surprised that none of the eight Boston-based companies on Luke's list didn't have SBIR/STTR funding. Boston is doing--or can do--deals, right? But then I thought more about the heat map. Certainly Massachusetts has it's fair share of academic/research institutions that can crank out life science technology to support SBIR/STTR proposals. Is there a correlation between the number of SBIR/STTR awards in Massachusetts and The Entrepreneurial Diaspora Enabled By Biotech M&A, particularly in the Boston MSA?

In other words, is it more apt to happen that a PI will hook up with a recycled talented team?